Table 2

Unadjusted and adjusted mean (95% CI) HbA1c levels (%), stratified by risk of OSA, self-reported daily sleep duration, and self-reported insomnia complaints

Sleep characteristicsHbA1c (%)
UnadjustedModel 1Model 2Model 2a
OSA risk
 Low risk (n=7778)7.17 (7.15 to 7.20)7.17 (7.15 to 7.20)7.20 (7.17 to 7.23)7.18 (7.16 to 7.21)
 High risk (n=5568)7.27 (7.24 to 7.30)7.26 (7.23 to 7.29)7.23 (7.20 to 7.27)7.25 (7.22 to 7.28)
 P value for main effect of OSA<0.001<0.0010.220.004
Sleep duration
 ≤6 hours (n=3728)7.27 (7.23 to 7.31)7.26 (7.21 to 7.29)7.24 (7.19 to 7.27)
 7–8 hours (n=7755)7.17 (7.14 to 7.19)7.17 (7.14 to 7.19)7.18 (7.16 to 7.21)
 ≥9 hours (n=1863)7.28 (7.23 to 7.35)7.31 (7.26 to 7.37)7.28 (7.23 to 7.34)
 P value for main effect of sleep duration<0.001<0.0010.003
Insomnia symptoms
 Never/rarely/sometimes (n=8574)7.20 (7.17 to 7.23)7.20 (7.17 to 7.22)7.20 (7.17 to 7.23)
 Usually (n=4772)7.24 (7.20 to 7.27)7.24 (7.20 to 7.27)7.23 (7.19 to 7.27)
 P value for main effect of insomnia symptoms0.130.080.41
  • Model 1: independent variables: age, sex, sleep duration, OSA risk, and insomnia symptoms; dependent variable: HbA1c.

  • Model 2: independent variables: age, sex, sleep duration, OSA risk, insomnia symptoms, UK Biobank assessment center, ethnic background, Townsend index, BMI, systolic blood pressure, smoking status, level of physical activity, diabetes regimen, and diabetes duration; dependent variable: HbA1c.

  • Model 2a: independent variables: age, sex, sleep duration, OSA risk, insomnia symptoms, UK Biobank assessment center, ethnic background, Townsend index, smoking status, level of physical activity, diabetes regimen, and diabetes duration; dependent variable: HbA1c. BMI and systolic blood pressure were not included in model 2a as both variables were used to estimate the risk of OSA.

  • BMI, body mass index; HbA1c, hemoglobin A1c; OSA, obstructive sleep apnea.